R T Ottow - JoVE Visualize

Showing results (11-20 of 15) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 15 results.

Journal of the National Cancer Institute|November 1, 1987

Augmentation of interleukin-2 immunotherapeutic effects by lymphokine-activated killer cells and allogeneic stimulation in murine tumor cellsA M Eggermont, E P Steller, R T Ottow, et al.

Annals of Surgery|February 1, 1985

Hepatic resection of colorectal metastases. Influence of clinical factors and adjuvant intraperitoneal 5-fluorouracil via Tenckhoff catheter on survivalD A August, P H Sugarbaker, R T Ottow, et al.

Cellular Immunology|February 1, 1987

Immunotherapy of intraperitoneal cancer with interleukin 2 and lymphokine-activated killer cells reduces tumor load and prolongs survival in murine modelsR T Ottow, E P Steller, P H Sugarbaker, et al.

Cancer Detection and Prevention|January 1, 1988

Local conditions in the host influence immunotherapy with interleukin-2 and LAK cellsE P Steller, R T Ottow, A M Eggermont, et al.

Cancer Research|November 15, 1987

Fate of gamma-interferon-activated killer blood monocytes adoptively transferred into the abdominal cavity of patients with peritoneal carcinomatosisH C Stevenson, A M Keenan, C Woodhouse, et al.

Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 15 results.

Journal of the National Cancer Institute|November 1, 1987

Augmentation of interleukin-2 immunotherapeutic effects by lymphokine-activated killer cells and allogeneic stimulation in murine tumor cellsA M Eggermont, E P Steller, R T Ottow, et al.

Annals of Surgery|February 1, 1985

Hepatic resection of colorectal metastases. Influence of clinical factors and adjuvant intraperitoneal 5-fluorouracil via Tenckhoff catheter on survivalD A August, P H Sugarbaker, R T Ottow, et al.

Cellular Immunology|February 1, 1987

Immunotherapy of intraperitoneal cancer with interleukin 2 and lymphokine-activated killer cells reduces tumor load and prolongs survival in murine modelsR T Ottow, E P Steller, P H Sugarbaker, et al.

Cancer Detection and Prevention|January 1, 1988

Local conditions in the host influence immunotherapy with interleukin-2 and LAK cellsE P Steller, R T Ottow, A M Eggermont, et al.

Cancer Research|November 15, 1987

Fate of gamma-interferon-activated killer blood monocytes adoptively transferred into the abdominal cavity of patients with peritoneal carcinomatosisH C Stevenson, A M Keenan, C Woodhouse, et al.

Pageof 2